Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
We identified an autosomal recessive infantile-onset symptomatic epilepsy syndrome associated with developmental stagnation and blindness. Assuming a founder effect in a large Old Order Amish pedigree, we carried out a genome-wide screen for linkage and identified a single region of homozygosity on chromosome 2p12-p11.2 spanning 5.1 cM (maximum lod score of 6.84). We sequenced genes in the region and identified a nonsense mutation in SIAT9, which is predicted to result in the premature termination of the GM3 synthase enzyme (also called lactosylceramide alpha-2,3 sialyltransferase). GM3 synthase is a member of the sialyltransferase family and catalyzes the initial step in the biosynthesis of most complex gangliosides from lactosylceramide. Biochemical analysis of plasma glycosphingolipids confirmed that affected individuals lack GM3 synthase activity, as marked by a complete lack of GM3 ganglioside and its biosynthetic derivatives and an increase in lactosylceramide and its alternative derivatives. Although the relationship between defects in ganglioside catabolism and a range of lysosomal storage diseases is well documented, this is the first report, to our knowledge, of a disruption of ganglioside biosynthesis associated with human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Munro, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00882-1 · Cited by 1,514
Enhanced insulin sensitivity in mice lacking ganglioside GM3
Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0635898100 · Cited by 531
Mice Expressing Only Monosialoganglioside GM3 Exhibit Lethal Audiogenic Seizures
Kawai, H., Allende, M. L., Wada, R., Kono, M., Sango, K., Deng, C., Miyakawa, T., Crawley, J. N., Werth, N., Bierfreund, U., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000847200 · Cited by 227
Gangliosides as modulators of cell function
Zeller, C. B., & Marchase, R. B. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.262.6.c1341 · Cited by 208
Biosynthesis and degradation of mammalian glycosphingolipids
Sandhoff, K., & Kolter, T. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1265 · Cited by 183
Neville, D. C. A., Coquard, V., Priestman, D. A., te Vruchte, D. J. M., Sillence, D. J., Dwek, R. A., Platt, F. M., & Butters, T. D. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.03.051 · Cited by 178
Self-citationTraveling for the glycosphingolipid path
Hakomori, S.-I. (2000) · Glycoconjugate Journal · doi:10.1023/a:1011086929064 · Cited by 178
Wraith, J. E. (2002) · Seminars in Neonatology · doi:10.1053/siny.2001.0088 · Cited by 166
Refractory Skin Injury in Complex Knock-out Mice Expressing Only the GM3 Ganglioside
Inoue, M., Fujii, Y., Furukawa, K., Okada, M., Okumura, K., Hayakawa, T., Furukawa, K., & Sugiura, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201631200 · Cited by 107
Glycosphingolipid functions: insights from engineered mouse models
Proia, R. L. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1268 · Cited by 84
Cited by
Glycosylation in Cellular Mechanisms of Health and Disease
Ohtsubo, K., & Marth, J. D. (2006) · Cell · doi:10.1016/j.cell.2006.08.019 · Cited by 2,788
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“phenotypes (405, 406), humans with similar defects suffer from severe multisystem disease (407, 408).”
BackgroundSialic acids in human health and disease
Varki, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.06.002 · Cited by 999
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Merrill, A. H. (2011) · Chemical Reviews · doi:10.1021/cr2002917 · Cited by 785
Schnaar, R. L., Gerardy-Schahn, R., & Hildebrandt, H. (2014) · Physiological Reviews · doi:10.1152/physrev.00033.2013 · Cited by 745
Genetic defects in the human glycome
Freeze, H. H. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1894 · Cited by 467
Structures, Biosynthesis, and Functions of Gangliosides-an Overview
Yu, R. K., Tsai, Y.-T., Ariga, T., & Yanagisawa, M. (2011) · Journal of Oleo Science · doi:10.5650/jos.60.537 · Cited by 416
Virus–Receptor Interactions: The Key to Cellular Invasion
Maginnis, M. S. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.024 · Cited by 413
Sphingolipid metabolism diseases
Kolter, T., & Sandhoff, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.027 · Cited by 367
Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications
Sipione, S., Monyror, J., Galleguillos, D., Steinberg, N., & Kadam, V. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.572965 · Cited by 325
Sphingolipid lysosomal storage disorders
Platt, F. M. (2014) · Nature · doi:10.1038/nature13476 · Cited by 320
Self-citationSphingolipids: membrane microdomains in brain development, function and neurological diseases
Olsen, A. S. B., & Færgeman, N. J. (2017) · Open Biology · doi:10.1098/rsob.170069 · Cited by 311
Metabolic glycoengineering: Sialic acid and beyond
Du, J., Meledeo, M. A., Wang, Z., Khanna, H. S., Paruchuri, V. D. P., & Yarema, K. J. (2009) · Glycobiology · doi:10.1093/glycob/cwp115 · Cited by 299
Glycosphingolipids—Nature, Function, and Pharmacological Modulation
Wennekes, T., van den Berg, R. J. B. H. N., Boot, R. G., van der Marel, G. A., Overkleeft, H. S., & Aerts, J. M. F. G. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200902620 · Cited by 288
Congenital Disorders of Glycosylation: A Rapidly Expanding Disease Family
Jaeken, J., & Matthijs, G. (2007) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.8.080706.092327 · Cited by 287
Gangliosides and Gangliosidoses: Principles of Molecular and Metabolic Pathogenesis
Sandhoff, K., & Harzer, K. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0822-13.2013 · Cited by 280
Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction
Posse de Chaves, E., & Sipione, S. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.12.010 · Cited by 274
The role of glycosphingolipid metabolism in the developing brain
Yu, R. K., Nakatani, Y., & Yanagisawa, M. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800028-jlr200 · Cited by 268
Metabolism and functions of lipids in myelin
Schmitt, S., Cantuti Castelvetri, L., & Simons, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.016 · Cited by 259
Neurological Aspects of Human Glycosylation Disorders
Freeze, H. H., Eklund, E. A., Ng, B. G., & Patterson, M. C. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-034019 · Cited by 245
Congenital disorders of glycosylation
Chang, I. J., He, M., & Lam, C. T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.10.45 · Cited by 235
Yamashita, T., Wu, Y.-P., Sandhoff, R., Werth, N., Mizukami, H., Ellis, J. M., Dupree, J. L., Geyer, R., Sandhoff, K., & Proia, R. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407785102 · Cited by 229
Congenital disorders of glycosylation
Jaeken, J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05840.x · Cited by 223
Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses
Butters, T. D., Dwek, R. A., & Platt, F. M. (2005) · Glycobiology · doi:10.1093/glycob/cwi076 · Cited by 218
Self-citationDevelopmental changes of glycosphingolipids and expression of glycogenes in mouse brains
Ngamukote, S., Yanagisawa, M., Ariga, T., Ando, S., & Yu, R. K. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04910.x · Cited by 217
Genetic Determinants of Circulating Sphingolipid Concentrations in European Populations
Hicks, A. A., Pramstaller, P. P., Johansson, Å., Vitart, V., Rudan, I., Ugocsai, P., Aulchenko, Y., Franklin, C. S., Liebisch, G., Erdmann, J., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000672 · Cited by 214
Gangliosides: glycosphingolipids essential for normal neural development and function
Schengrund, C.-L. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.03.007 · Cited by 211
Functional Roles of Gangliosides in Neurodevelopment: An Overview of Recent Advances
Yu, R. K., Tsai, Y.-T., & Ariga, T. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0744-y · Cited by 203
Neurology of inherited glycosylation disorders
Freeze, H. H., Eklund, E. A., Ng, B. G., & Patterson, M. C. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70040-6 · Cited by 201
Susuki, K., Baba, H., Tohyama, K., Kanai, K., Kuwabara, S., Hirata, K., Furukawa, K., Furukawa, K., Rasband, M. N., & Yuki, N. (2007) · Glia · doi:10.1002/glia.20503 · Cited by 201
Gangliosides of the Vertebrate Nervous System
Schnaar, R. L. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.05.020 · Cited by 199
Lysosomal Lipid Storage Diseases
Schulze, H., & Sandhoff, K. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004804 · Cited by 195
Pan, B., Fromholt, S. E., Hess, E. J., Crawford, T. O., Griffin, J. W., Sheikh, K. A., & Schnaar, R. L. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.04.017 · Cited by 194
Alteration of Ganglioside Biosynthesis Responsible for Complex Hereditary Spastic Paraplegia
Boukhris, A., Schule, R., Loureiro, J. L., Lourenço, C. M., Mundwiller, E., Gonzalez, M. A., Charles, P., Gauthier, J., Rekik, I., Acosta Lebrigio, R. F., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.05.006 · Cited by 184
Lysosomal Storage Disorders in the Newborn
Staretz-Chacham, O., Lang, T. C., LaMarca, M. E., Krasnewich, D., & Sidransky, E. (2009) · Pediatrics · doi:10.1542/peds.2008-0635 · Cited by 186
Boccuto, L., Aoki, K., Flanagan-Steet, H., Chen, C.-F., Fan, X., Bartel, F., Petukh, M., Pittman, A., Saul, R., Chaubey, A., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt434 · Cited by 182
Jennemann, R., Sandhoff, R., Wang, S., Kiss, E., Gretz, N., Zuliani, C., Martin-Villalba, A., Jäger, R., Schorle, H., Kenzelmann, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500893102 · Cited by 178
Fantini, J., & Yahi, N. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001602 · Cited by 173
The Role of Gangliosides in Neurodevelopment
Palmano, K., Rowan, A., Guillermo, R., Guan, J., & McJarrow, P. (2015) · Nutrients · doi:10.3390/nu7053891 · Cited by 173
Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans
Wu, G., Lu, Z., Kulkarni, N., & Ledeen, R. W. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23090 · Cited by 167
Multi-system disorders of glycosphingolipid and ganglioside metabolism
Xu, Y.-H., Barnes, S., Sun, Y., & Grabowski, G. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r003996 · Cited by 166
Kolter, T. (2012) · ISRN Biochemistry · doi:10.5402/2012/506160 · Cited by 165
NANS-mediated synthesis of sialic acid is required for brain and skeletal development
van Karnebeek, C. D. M., Bonafé, L., Wen, X.-Y., Tarailo-Graovac, M., Balzano, S., Royer-Bertrand, B., Ashikov, A., Garavelli, L., Mammi, I., Turolla, L., et al. (2016) · Nature Genetics · doi:10.1038/ng.3578 · Cited by 164
Martinez-Duncker, I. (2005) · Blood · doi:10.1182/blood-2004-09-3509 · Cited by 162
Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins
Mocchetti, I. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5188-y · Cited by 160
Physiology of gangliosides and the role of antiganglioside antibodies in human diseases
Cutillo, G., Saariaho, A.-H., & Meri, S. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0388-9 · Cited by 170
Brain gangliosides in axon–myelin stability and axon regeneration
Schnaar, R. L. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.10.011 · Cited by 152
Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
Harlalka, G. V., Lehman, A., Chioza, B., Baple, E. L., Maroofian, R., Cross, H., Sreekantan-Nair, A., Priestman, D. A., Al-Turki, S., McEntagart, M. E., et al. (2013) · Brain · doi:10.1093/brain/awt270 · Cited by 144
Self-citationLipid rafts: Keys to neurodegeneration
Schengrund, C. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.02.013 · Cited by 154
Sphingolipid metabolism in neural cells
van Echten‐Deckert, G., & Herget, T. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.06.009 · Cited by 160
Impaired Ganglioside Metabolism in Huntington's Disease and Neuroprotective Role of GM1
Maglione, V., Marchi, P. M., Pardo, A. D., Lingrell, S., Horkey, M., Tidmarsh, E., & Sipione, S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.6348-09.2010 · Cited by 150
Sialylation and Galectin-3 in Microglia-Mediated Neuroinflammation and Neurodegeneration
Puigdellívol, M., Allendorf, D. H., & Brown, G. C. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00162 · Cited by 141
Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation
Lam, C. T., Ferreira, C. R., Krasnewich, D. M., Toro, C., Latham, L. L., Zein, W. M., Lehky, T., Brewer, C. C., Baker, E. H., Thurm, A. E., et al. (2016) · Genetics in Medicine · doi:10.1038/gim.2016.75 · Cited by 142
Ginkel, C., Hartmann, D., vom Dorp, K., Zlomuzica, A., Farwanah, H., Eckhardt, M., Sandhoff, R., Degen, J., Rabionet, M., Dere, E., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.413500 · Cited by 135
Deregulated Sphingolipid Metabolism and Membrane Organization in Neurodegenerative Disorders
Piccinini, M., Scandroglio, F., Prioni, S., Buccinnà, B., Loberto, N., Aureli, M., Chigorno, V., Lupino, E., Marco, G. D., Lomartire, A., et al. (2010) · Molecular Neurobiology · doi:10.1007/s12035-009-8096-6 · Cited by 142
The expression and functions of glycoconjugates in neural stem cells
Yanagisawa, M., & Yu, R. K. (2007) · Glycobiology · doi:10.1093/glycob/cwm018 · Cited by 147
Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency
Fragaki, K., Ait-El-Mkadem, S., Chaussenot, A., Gire, C., Mengual, R., Bonesso, L., Bénéteau, M., Ricci, J., Desquiret‐Dumas, V., Procaccio, V., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.202 · Cited by 142
Role of Sphingolipid Metabolism in Neurodegeneration
Alaamery, M., Albesher, N., Aljawini, N., Alsuwailm, M., Massadeh, S., Wheeler, M. A., Chao, C., & Quintana, F. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15044 · Cited by 129
Diseases of glycosylation beyond classical congenital disorders of glycosylation
Hennet, T. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.02.001 · Cited by 127
Dietary Polar Lipids and Cognitive Development: A Narrative Review
Zheng, L. P., Fleith, M., Giuffrida, F., O’Neill, B. V., & Schneider, N. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz051 · Cited by 137
How Do Gangliosides Regulate RTKs Signaling?
Julien, S., Bobowski, M., Steenackers, A., Bourhis, X. L., & Delannoy, P. (2013) · Cells · doi:10.3390/cells2040751 · Cited by 136
DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans
Karsai, G., Kraft, F., Haag, N., Korenke, G. C., Hänisch, B., Othman, A., Suriyanarayanan, S., Steiner, R., Knopp, C., Mull, M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124159 · Cited by 121
Schnaar, R. L. (2018) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/bs.accb.2018.09.002 · Cited by 135
Gangliosides: Treatment Avenues in Neurodegenerative Disease
Magistretti, P. J., Geisler, F. H., Schneider, J. S., Li, P. A., Fiumelli, H., & Sipione, S. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00859 · Cited by 124
Glycolipids and Lectins in Endocytic Uptake Processes
Johannes, L., Wunder, C., & Shafaq‐Zadah, M. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.10.027 · Cited by 128
Congenital Disorders of Glycosylation from a Neurological Perspective
Paprocka, J., Jezela‐Stanek, A., Tylki‐Szymańska, A., & Grünewald, S. (2021) · Brain Sciences · doi:10.3390/brainsci11010088 · Cited by 133
Emerging concepts of ganglioside metabolism
Sandhoff, R., & Sandhoff, K. (2018) · FEBS Letters · doi:10.1002/1873-3468.13114 · Cited by 128
Wu, G., Lu, Z.-H., Wang, J., Wang, Y., Xie, X., Meyenhofer, M. F., & Ledeen, R. W. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3635-05.2005 · Cited by 114
Glycosylation diseases: Quo vadis?
Schachter, H., & Freeze, H. H. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.002 · Cited by 111
Congenital disorders of glycosylation
Jaeken, J. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00044-7 · Cited by 122
Sphingolipids and lysosomal pathologies
Schulze, H., & Sandhoff, K. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.10.015 · Cited by 126
Lamari, F., Mochel, F., Sedel, F., & Saudubray, J. M. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9509-7 · Cited by 104
A view on sphingolipids and disease
Kolter, T. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.04.013 · Cited by 120
Sialylation regulates brain structure and function
Yoo, S., Motari, M. G., Susuki, K., Prendergast, J., Mountney, A., Hurtado, A., & Schnaar, R. L. (2015) · The FASEB Journal · doi:10.1096/fj.15-270983 · Cited by 101
Differential Distribution of Major Brain Gangliosides in the Adult Mouse Central Nervous System
Vajn, K., Viljetić, B., Degmečić, I. V., Schnaar, R. L., & Heffer, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075720 · Cited by 111
Lipid glycosylation: a primer for histochemists and cell biologists
Kopitz, J. (2016) · Histochemistry and Cell Biology · doi:10.1007/s00418-016-1518-4 · Cited by 104
Glycosphingolipid metabolism in cell fate specification
Russo, D., Capolupo, L., Loomba, J. S., Sticco, L., & D’Angelo, G. (2018) · Journal of Cell Science · doi:10.1242/jcs.219204 · Cited by 94
Hülsmeier, A. J., Burda, P., & Hennet, T. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700361-mcp200 · Cited by 94
Defective Mitochondrial mRNA Maturation Is Associated with Spastic Ataxia
Crosby, A. H., Patel, H., Chioza, B. A., Proukakis, C., Gurtz, K., Patton, M. A., Sharifi, R., Harlalka, G. V., Simpson, M. A., Dick, K. J., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.09.013 · Cited by 91
Self-citationPlomp, J. J., & Willison, H. J. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.171702 · Cited by 97
de Kovel, C. G. F., Brilstra, E. H., van Kempen, M. J. A., Slot, R. V. ‘., Nijman, I. J., Afawi, Z., Jonghe, P. D., Djémié, T., Guerrini, R., Hardies, K., et al. (2016) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.235 · Cited by 95
Dewald, J., Colomb, F., Bobowski-Gerard, M., Groux-Degroote, S., & Delannoy, P. (2016) · Cells · doi:10.3390/cells5040043 · Cited by 84
Glycosphingolipid metabolic reprogramming drives neural differentiation
Russo, D., Ragione, F. D., Rizzo, R., Sugiyama, E., Scalabrì, F., Hori, K., Capasso, S., Sticco, L., Fioriniello, S., Gregorio, R. D., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201797674 · Cited by 85
Ganglioside GM3 and its biological functions
Prokazova, N. V., Samovilova, N. N., Gracheva, E. V., & Golovanova, N. K. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909030018 · Cited by 95
Golgi Glycosylation and Human Inherited Diseases
Freeze, H. H., & Ng, B. G. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005371 · Cited by 81
On the nomenclature of congenital disorders of glycosylation (CDG)
Jaeken, J., Hennet, T., Freeze, H. H., & Matthijs, G. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0983-x · Cited by 77
A perilous path: the inborn errors of sphingolipid metabolism
Dunn, T. M., Tifft, C. J., & Proia, R. L. (2019) · Journal of Lipid Research · doi:10.1194/jlr.s091827 · Cited by 84
Zahka, K. G., Kalidas, K., Simpson, M. A., Cross, H. E., Keller, B. B., Galambos, C., Gurtz, K., Patton, M. A., & Crosby, A. H. (2008) · Heart · doi:10.1136/hrt.2007.127241 · Cited by 74
Self-citationGanglioside Metabolism in Health and Disease
Sandhoff, R., Schulze, H., & Sandhoff, K. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.01.002 · Cited by 80
Gangliosides, α-Synuclein, and Parkinson's Disease
Ledeen, R. W., & Wu, G. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.12.009 · Cited by 77
Functions of sphingolipid metabolism in mammals — Lessons from genetic defects
Sabourdy, F., Kedjouar, B., Sorli, S., Colié, S., Milhas, D., Salma, Y., & Levade, T. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.01.004 · Cited by 81
Anti-inflammatory role of GM1 and other gangliosides on microglia
Galleguillos, D., Wang, Q., Steinberg, N., Zaidi, A. K., Shrivastava, G., Dhami, K., Daskhan, G. C., Schmidt, E. N., Dworsky-Fried, Z., Giuliani, F., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02374-x · Cited by 78
Jennemann, R., & Gröne, H. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.02.001 · Cited by 74
Gangliosides of the Nervous System
Ledeen, R. W., & Wu, G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8552-4_2 · Cited by 78
Inokuchi, J., Inamori, K., Kabayama, K., Nagafuku, M., Uemura, S., Go, S., Suzuki, A., Ohno, I., Kanoh, H., & Shishido, F. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.10.004 · Cited by 70
Ganglioside GM1 and the Central Nervous System
Guo, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119558 · Cited by 82
Pasquale, E. D., Fantini, J., Chahinian, H., Maresca, M., Taïeb, N., & Yahi, N. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.046 · Cited by 71
Identification of host cell factors required for intoxication through use of modified cholera toxin
Guimaraes, C. P., Carette, J. E., Varadarajan, M., Antos, J., Popp, M. W., Spooner, E., Brummelkamp, T. R., & Ploegh, H. L. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201108103 · Cited by 66
Joshi, H. J., Hansen, L. H., Narimatsu, Y., Freeze, H. H., Henrissat, B., Bennett, E., Wandall, H. H., Clausen, H., & Schjoldager, K. T.-B. G. (2018) · Glycobiology · doi:10.1093/glycob/cwy015 · Cited by 69
Keeping it trim: roles of neuraminidases in CNS function
Pshezhetsky, A. V., & Ashmarina, M. (2018) · Glycoconjugate Journal · doi:10.1007/s10719-018-9837-4 · Cited by 62
Metadata
- Authors
- Simpson, M. A., Cross, H., Proukakis, C., Priestman, D. A., Neville, D. C. A., Reinkensmeier, G., Wang, H., Wiznitzer, M., Gurtz, K., Verganelaki, A., Pryde, A., Patton, M. A., Dwek, R. A., Butters, T. D., Platt, F. M., & Crosby, A. H.
- Affiliations
- University of London (GB)
- University of Arizona (US)
- University of Oxford (GB)
- Rainbow Babies & Children's Hospital (US)
- Corresponding author
- Crosby, Andrew H
- ORCID
- Venue
- Nature Genetics
- Published
- 2004-10-24
- Volume
- 36
- Issue
- 11
- Pages
- 1225-1229
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2161292836
- Cited by
- 389
- References
- 22
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 17 · 2023: 20 · 2022: 25 · 2021: 18 · 2020: 25 · 2019: 15 · 2018: 29 · 2017: 11 · 2016: 19 · 2015: 16 · 2014: 27 · 2013: 19 · 2012: 18
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Research to Prevent Blindness
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- GM3 synthase, loss-of-function mutations, autosomal recessive inheritance, founder effect, Old Order Amish, ganglioside biosynthesis, GM3 ganglioside, lactosylceramide, glycosphingolipids, blindness, sialyltransferase, linkage mapping
- MeSH terms
- Blindness, Developmental Disabilities, Chromosomes, Human, Pair 2, Epilepsy, Female, G(M3) Ganglioside, Genes, Recessive, Glycosphingolipids, Humans, Infant, Infant, Newborn, Male, Pedigree, Sialyltransferases, Syndrome, Codon, Nonsense, Founder Effect
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.